ABT Balance Sheet
Abbott Laboratories - Assets, Liabilities & Stockholders' Equity
Total Assets
$81.41B
Total Liabilities
$81.41B
Shareholders' Equity
$47.66B
Cash Position
$7.62B
Assets
As of: FY
Current Assets
Cash & Equivalents
$7.62B
Total Current Assets
$23.66B
Non-Current Assets
Total Assets
$81.41B
Liabilities & Equity
Current Liabilities
Total Current Liabilities
$14.16B
Non-Current Liabilities
Total Liabilities
$81.41B
Stockholders' Equity
Retained Earnings
$47.26B
Total Equity
$47.66B
Total Liabilities & Equity
$81.41B
Should equal Total Assets
Key Balance Sheet Ratios
Current Ratio
1.67
Current Assets / Current Liabilities
Working Capital
$9.50B
Current Assets - Current Liabilities
Balance Sheet Health
Liquidity: Strong
Current ratio of 1.67 indicates the company has ample short-term assets to cover short-term liabilities.
Cash Position: 9.4% of Assets
$7.62B in cash provides adequate financial flexibility.
View Complete Financial Analysis
Explore detailed financials, income statements, cash flows, and more
Open Full FinancialsFrequently Asked Questions
What are ABT's total assets?
ABT has total assets of $81.41B, down from $81.41B in the previous period.
How much debt does ABT have?
Debt information for ABT can be found in the balance sheet.
What is ABT's cash position?
ABT has $7.62B in cash and cash equivalents, representing 9.4% of total assets.
What is ABT's stockholders' equity?
ABT's stockholders' equity is $47.66B. This represents the book value of the company and shareholder ownership stake.
What is ABT's current ratio?
ABT has a current ratio of 1.67. This means the company has $1.67 in current assets for every $1 in current liabilities. A ratio above 1.0 indicates good short-term financial health.
How healthy is ABT's balance sheet?
ABT's balance sheet shows $81.41B in total assets, $81.41B in liabilities, and $47.66B in equity. The current ratio of 1.67 suggests adequate liquidity.